Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
Fu D, Yan J, Zhang Z, Liu Y, Ma X, Ding J, Yang S, Zhao R, Chang A, Gao C, Liu J, Zhao T, Wang X, Huang C, Gao S, Ma Y, Tang B, Feng Y, Wang H, Hao J.
Fu D, et al. Among authors: tang b.
Cancer Biol Med. 2023 Jun 27;20(8):599-626. doi: 10.20892/j.issn.2095-3941.2023.0039.
Cancer Biol Med. 2023.
PMID: 37381714
Free PMC article.